-
Company Insights
Innovation and Patenting activity of iNtRON Biotechnology Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of iNtRON Biotechnology Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Xempritolimod in Oral Mucositis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Xempritolimod in Oral Mucositis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Xempritolimod in Oral Mucositis Drug Details: Xempritolimod (KMRC-011) is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Zilovertamab Vedotin in Burkitt Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Zilovertamab Vedotin in Burkitt Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Zilovertamab Vedotin in Burkitt Lymphoma Drug Details: Zilovertamab vedotin is...
-
Track & Monitor
Microbiome in pharma: bacteriophage therapy
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the pharma industry’s bacteriophage therapy segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based on...
-
Product Insights
Endocarditis – Drugs In Development, 2023
Global Markets Direct’s, ‘Endocarditis - Drugs In Development, 2023’, provides an overview of the Endocarditis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Endocarditis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Stomatitis (Sore Mouth) – Drugs In Development, 2023
Global Markets Direct’s, ‘Stomatitis (Sore Mouth) - Drugs In Development, 2023’, provides an overview of the Stomatitis (Sore Mouth) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Stomatitis (Sore Mouth), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Oral Mucositis – Drugs In Development, 2023
Global Markets Direct’s, ‘Oral Mucositis - Drugs In Development, 2023’, provides an overview of the Oral Mucositis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Oral Mucositis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Endomyocardial (Eosinophilic) Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Endomyocardial (Eosinophilic) Disease - Drugs In Development, 2023’, provides an overview of the Endomyocardial (Eosinophilic) Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Endomyocardial (Eosinophilic) Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Anthrax – Drugs In Development, 2023
Global Markets Direct’s, ‘Anthrax - Drugs In Development, 2023’, provides an overview of the Anthrax pipeline landscape. The report provides comprehensive information on the therapeutics under development for Anthrax, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Escherichia coli Infections – Drugs In Development, 2023
Global Markets Direct’s, ‘Escherichia coli Infections - Drugs In Development, 2023’, provides an overview of the Escherichia coli Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Escherichia coli Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...